PDIA3 and breast carcinoma: The correlation of PDIA3 with DMFS in several breast cancer subtypes, whereas transcripts encoding the extracellular proteins from our data set correlated specifically with poor DMFS outcomes in basal-type breast cancer, may suggest that PDIA3 has a different substrate repertoire in other molecular subtypes.